205 related articles for article (PubMed ID: 28242240)
1. NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice.
Krones E; Eller K; Pollheimer MJ; Racedo S; Kirsch AH; Frauscher B; Wahlström A; Ståhlman M; Trauner M; Grahammer F; Huber TB; Wagner K; Rosenkranz AR; Marschall HU; Fickert P
J Hepatol; 2017 Jul; 67(1):110-119. PubMed ID: 28242240
[TBL] [Abstract][Full Text] [Related]
2. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.
Fickert P; Krones E; Pollheimer MJ; Thueringer A; Moustafa T; Silbert D; Halilbasic E; Yang M; Jaeschke H; Stokman G; Wells RG; Eller K; Rosenkranz AR; Eggertsen G; Wagner CA; Langner C; Denk H; Trauner M
Hepatology; 2013 Dec; 58(6):2056-69. PubMed ID: 23813550
[TBL] [Abstract][Full Text] [Related]
3. Cholemic nephropathy - Historical notes and novel perspectives.
Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
[TBL] [Abstract][Full Text] [Related]
4. Bile acids in cholestasis: bad for the liver, not so good for the kidney.
Erlinger S
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):392-4. PubMed ID: 24726271
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of norUDCA and UDCA in obstructive cholestasis in mice.
Fickert P; Pollheimer MJ; Silbert D; Moustafa T; Halilbasic E; Krones E; Durchschein F; Thüringer A; Zollner G; Denk H; Trauner M
J Hepatol; 2013 Jun; 58(6):1201-8. PubMed ID: 23369794
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
[TBL] [Abstract][Full Text] [Related]
7. Cholemic Nephropathy: Role in Acute Kidney Injury in Cholestasis and Cirrhosis.
Pinter K; Rosenkranz A
Adv Kidney Dis Health; 2024 Mar; 31(2):111-126. PubMed ID: 38649215
[TBL] [Abstract][Full Text] [Related]
8. Bile acid-induced cholemic nephropathy.
Krones E; Wagner M; Eller K; Rosenkranz AR; Trauner M; Fickert P
Dig Dis; 2015; 33(3):367-75. PubMed ID: 26045271
[TBL] [Abstract][Full Text] [Related]
9. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.
Halilbasic E; Fiorotto R; Fickert P; Marschall HU; Moustafa T; Spirli C; Fuchsbichler A; Gumhold J; Silbert D; Zatloukal K; Langner C; Maitra U; Denk H; Hofmann AF; Strazzabosco M; Trauner M
Hepatology; 2009 Jun; 49(6):1972-81. PubMed ID: 19475687
[TBL] [Abstract][Full Text] [Related]
10. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Fickert P; Wagner M; Marschall HU; Fuchsbichler A; Zollner G; Tsybrovskyy O; Zatloukal K; Liu J; Waalkes MP; Cover C; Denk H; Hofmann AF; Jaeschke H; Trauner M
Gastroenterology; 2006 Feb; 130(2):465-81. PubMed ID: 16472600
[TBL] [Abstract][Full Text] [Related]
11. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
[TBL] [Abstract][Full Text] [Related]
12. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
[TBL] [Abstract][Full Text] [Related]
13. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
14. 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
Sombetzki M; Fuchs CD; Fickert P; Österreicher CH; Mueller M; Claudel T; Loebermann M; Engelmann R; Langner C; Sahin E; Schwinge D; Guenther ND; Schramm C; Mueller-Hilke B; Reisinger EC; Trauner M
J Hepatol; 2015 Apr; 62(4):871-8. PubMed ID: 25463533
[TBL] [Abstract][Full Text] [Related]
15. Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.
Ommati MM; Farshad O; Azarpira N; Ghazanfari E; Niknahad H; Heidari R
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1301-1314. PubMed ID: 33538845
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
[TBL] [Abstract][Full Text] [Related]
17. Bile Cast Nephropathy Caused by Obstructive Cholestasis.
Aniort J; Poyet A; Kemeny JL; Philipponnet C; Heng AE
Am J Kidney Dis; 2017 Jan; 69(1):143-146. PubMed ID: 27780576
[TBL] [Abstract][Full Text] [Related]
18. 24-Norursodeoxycholic acid reshapes immunometabolism in CD8
Zhu C; Boucheron N; Müller AC; Májek P; Claudel T; Halilbasic E; Baazim H; Lercher A; Viczenczova C; Hainberger D; Preglej T; Sandner L; Alteneder M; Gülich AF; Khan M; Hamminger P; Remetic J; Ohradanova-Repic A; Schatzlmaier P; Donner C; Fuchs CD; Stojakovic T; Scharnagl H; Sakaguchi S; Weichhart T; Bergthaler A; Stockinger H; Ellmeier W; Trauner M
J Hepatol; 2021 Nov; 75(5):1164-1176. PubMed ID: 34242699
[TBL] [Abstract][Full Text] [Related]
19. Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats.
Kaler B; Karram T; Morgan WA; Bach PH; Yousef IM; Bomzon A
Ren Fail; 2004 Sep; 26(5):507-16. PubMed ID: 15526908
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction as a mechanism involved in the pathogenesis of cirrhosis-associated cholemic nephropathy.
Heidari R; Mandegani L; Ghanbarinejad V; Siavashpour A; Ommati MM; Azarpira N; Najibi A; Niknahad H
Biomed Pharmacother; 2019 Jan; 109():271-280. PubMed ID: 30396085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
